Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

BeyondSpring Inc

BYSI
Current price
0.87 USD +0.014 USD (+1.64%)
Last closed 0.86 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 33 863 968 USD
Yield for 12 month +52.98 %
Week
Month
Year
BYSI
21.11.2021 - 28.11.2021

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers. In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York. Address: 28 Liberty Street, New York, NY, United States, 10005

Analytics

WallStreet Target Price

1.13 USD

P/E ratio

Dividend Yield

Current Year

+1 351 000 USD

Last Year

+1 351 000 USD

Current Quarter

+338 000 USD

Last Quarter

Current Year

+1 351 000 USD

Last Year

+1 351 000 USD

Current Quarter

+338 000 USD

Last Quarter

Key Figures BYSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -37 007 000 USD
Operating Margin TTM -2434.22 %
PE Ratio
Return On Assets TTM -36.4 %
PEG Ratio
Return On Equity TTM -310.48 %
Wall Street Target Price 1.13 USD
Revenue TTM 1 351 000 USD
Book Value -0.15 USD
Revenue Per Share TTM 0.035 USD
Dividend Share
Quarterly Revenue Growth YOY -0.1 %
Dividend Yield
Gross Profit TTM 1 351 000 USD
Earnings Share -0.85 USD
Diluted Eps TTM -0.85 USD
Most Recent Quarter I 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics BYSI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History BYSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation BYSI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 10.5374
Enterprise Value Revenue 1.1524
Price Sales TTM 25.0659
Enterprise Value EBITDA -0.0434
Price Book MRQ 5.3811

Financials BYSI

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators BYSI

For 52 weeks

0.54 USD 3.45 USD
50 Day MA 0.9 USD
Shares Short Prior Month 2 081 180
200 Day MA 1.09 USD
Short Ratio 25.57
Shares Short 2 040 607
Short Percent 8.62 %